Dopamine AgonistsDopamineErgolinesReceptors, Dopamine D2PergolideReceptors, DopamineBromocriptineReceptors, Dopamine D1Dopamine AntagonistsBenzothiazolesReceptors, Dopamine D3ApomorphineDopamine AgentsQuinpiroleAntiparkinson AgentsProlactinomaLisuride2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineLevodopaPiribedilDopamine Plasma Membrane Transport ProteinsBenzazepinesHyperprolactinemiaParkinson DiseaseImpulse Control DisordersCorpus StriatumDopamine Uptake InhibitorsHydroxydopaminesDomperidonePituitary NeoplasmsTetrahydronaphthalenesSpiperoneOxidopamineHaloperidolReceptors, Dopamine D5Restless Legs SyndromeProlactinSulpiridePsychoses, Substance-Inducedalpha-MethyltyrosineDose-Response Relationship, DrugGamblingDyskinesia, Drug-InducedDopamine beta-HydroxylaseCarbidopaAmphetamineSerotonin 5-HT2 Receptor AgonistsNucleus AccumbensBehavior, AnimalCocainePimozideRats, Sprague-DawleyGalactorrheaMotor ActivityStartle ReactionDextroamphetamineDeoxyepinephrineSubstantia NigraEntopeduncular NucleusJealousyAcromegalyClavicepsRewardRacloprideErgotamineAminoquinolinesCompulsive BehaviorParkinson Disease, SecondaryRNA IsoformsNeuronsPyrrolidinesMonoamine Oxidase InhibitorsGABA AgonistsBrainSalicylamidesLimbic SystemNeostriatum1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineCentral Nervous System StimulantsParkinsonian DisordersMetoclopramideRats, WistarAntipsychotic AgentsThiophenesIndolesDrug InteractionsRats, Inbred StrainsMicrodialysisAmantadineDopaminergic NeuronsNicotinic AgonistsTyrosine 3-MonooxygenaseHomovanillic AcidFenoldopamTime FactorsPurinergic P1 Receptor AgonistsDopamine and cAMP-Regulated Phosphoprotein 32Analysis of VarianceBasal GangliaMicroinjections